How to Buy Axonics Stock
Axonics Inc
Axonics, Inc. , a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems.
Axonics stock last closed at $56.82, down 1.83% from the previous day, and has decreased 13.77% in one year. It has overperformed other stocks in the Medical Devices industry by 0.05 percentage points. Axonics stock is currently +19.39% from its 52-week low of $47.59, and -17.57% from its 52-week high of $68.93.
As of Dec 8, 2023, there are 50.66M AXNX shares outstanding. The market cap of AXNX is $2.88B. In the past 24 hours, 566,509 AXNX shares were traded.
How to Buy Axonics Stock
Not sure how to invest in Axonics stock? Here's how.
- Figure out where to buy Axonics stock: You need to choose an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Axonics stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Select your payment method and add your details.
- Analyze Axonics stock: The Axonics ticker symbol is AXNX. Is Axonics stock a good investment? Should you buy shares of AXNX? How do AXNX's underlying business fundamentals look? Do top analysts think Axonics is a good buy? Why has AXNX's stock price moved recently? (Hint: Our stock research tools can help you understand if AXNX is a good stock to buy).
- Execute your AXNX trade: Decide if you will purchase AXNX shares at the current market price or use a limit order to purchase AXNX shares at a specific price.
- Get the latest news on your investment in AXNX: Create a watchlist to watch your new investment in Axonics shares.
Step 1: Figure out where to buy Axonics stock
You need an online brokerage account to access the NASDAQ market and buy AXNX shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Real Estate, New York to London — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal information so you can buy AXNX stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've created your account on the best stock trading app, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details transferring funds into your new brokerage account.
Step 4: Analyze Axonics stock
Once you have chosen the best place to buy Axonics stock, it's critical to research their stock prior to investing, so you can comprehend the risk as well as the upside.
Axonics Numbers
Axonics Due Diligence Checks
WallStreetZen was built to help average investors do better fundamental analysis.
You can view all of the due diligence checks on AXNX's stock page.
Is AXNX stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge AXNX's intrinsic value.
Using relative valuations ratios:
- AXNX could be overvalued based on its P/B ratio of 4.71x, relative to Medical Devices industry P/B ratio of 3.55x
You can access additional valuation research on AXNX's stock here.
AXNX Financials at a glance
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the AXNX balance sheet.
- AXNX has $344.72M in cash and short term investments. This is sufficient to cover its annual cash burn of $871.00k.
- AXNX profit margin has gone up from -31.4% to -3.5% in the past year.
- Total AXNX debt is lower than 5 years ago, relative to shareholder equity.
- AXNX has cash burn of 871000. It has enough cash and short-term investments to cover this for at least one year.
- AXNX has a low debt to equity ratio of 0.08.
- There are more short-term assets than long-term liabilities on the AXNX balance sheet.
Is it a good time to buy Axonics stock, according to Wall Street analysts?
Out of 8 sell side analysts who give recommendations on AXNX, the consensus analyst rating on AXNX is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent AXNX Analyst Forecasts
Matthew Mishan, a bottom 6% analyst from KeyBanc maintains AXNX with a strong buy rating and raises their AXNX price target from $70.00 to $71.00, on Jul 28, 2023.
Anthony Petrone, a bottom 16% analyst from Mizuho reiterates AXNX with a strong buy rating and maintains their AXNX price target from $75.00 to $75.00, on Jul 14, 2023.
Shagun Singh, a bottom 8% analyst from RBC Capital maintains AXNX with a buy rating and lowers their AXNX price target from $85.00 to $75.00, on Jul 12, 2023.
You can dive deeper into what analysts are projecting on the Axonics stock forecast page.
AXNX Technical Indicators
How are AXNX Revenues/Earnings doing?
Last year, AXNX revenue was $342.56M. In the last 5 year, AXNX's revenue has grown by 337.8% per year. This was faster than the Medical Devices industry average of 12.67%.
Dig into AXNX's earnings and revenue performance here.
Are AXNX insiders buying or selling the stock?
In the past 12 months, insiders at AXNX have sold more shares than they have bought.
Danny L. Dearen, President CFO of AXNX, was the latest AXNX insider to sell. They sold $436,492.60 worth of AXNX stock on Sep 29, 2023.
Get more info about who owns AXNX stock here.
Can I get consistent income from AXNX stock?
No, Axonics doesn't provide an income stream by paying out dividends.
What do other investors have to say about AXNX?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your AXNX trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open button and your broker will place your order.
If you require additional info about investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your investment in AXNX
Now that you own some shares in AXNX, you'll want to keep up with your new investment.
Add AXNX to a watchlist to get the latest updates about your AXNX stock.
AXNX Feed
How to Buy Stock in Axonics
To summarize, here are the 6 steps to buy Axonics stock:
- Figure out where to buy Axonics stock
- Create a brokerage account
- Deposit money your brokerage account
- Analyze Axonics stock
- Execute your AXNX trade
- Get the latest news on your investment in AXNX
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to track your investment in Axonics, click the button below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.